Company / Assets per Share
Aquestive Therapeutics, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.75
FY2025
5-year range
$1.05 / $1.79
FY2021-FY2025
Trend
+18.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.05 to $1.75 over the past 2 years.
Based on SEC 10-K filings.
1.75 in FY2025 with a 5-year CAGR of -1.3%.
Improved from $1.05 to $1.75 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +8.2%
- 5-Year CAGR
- -1.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 18.6% year-over-year.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.75 | +18.6% |
| FY2024 | $1.48 | +41.3% |
| FY2023 | $1.05 | -24.3% |
| FY2022 | $1.38 | -22.8% |
| FY2021 | $1.79 | -4.3% |
| FY2020 | $1.87 | -40.4% |
| FY2019 | $3.14 | -9.6% |
| FY2018 | $3.48 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026